Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /524322
chevron_leftBack
Kabra Drugs Ltd. logo

Kabra Drugs Ltd.

524322
• BSE: 524322 • Delayed
24.84INR -0.3%
0.2604 USD
As of 13 June 2026, Kabra Drugs Ltd. has a market cap of $6.18M USD, ranking #43589 globally and #3677 in India. It ranks #3865 in the Healthcare sector, and #269 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
43589
Country Rank
3677
Sector Rank
3865
Industry Rank
269
Key Stats
Market Cap
$6.18MUSD
588.9M INR
Enterprise Value
$5.0MUSD
476.61M INR
Revenue (TTM)
$6.01MUSD
573.34M INR
EBITDA (TTM)
$387.17KUSD
36.93M INR
Net Income (TTM)
$450.53KUSD
42.96M INR
EBITDA Margin
6.4%
Profit Margin
7.5%
PE Ratio
12.2
PS Ratio
1.0
PB Ratio
2.3
EV/EBITDA
12.9
Company Profile
Country (HQ)
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nanjappan Aravind open_in_new
Employees
31
Founded
1989
Website
kabradrugs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -7.4% -3.6% -16% 29% 124%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
524322 (KABRADG)
Kabra Drugs Ltd
ISIN: INE323K01017
TV:
BSE: KABRADG
SA:
BOM: 524322
YF:
524322.BO
GF:
BOM: 524322
BA:
524322
MS:
XBOM: 524322
24.84 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kabra Drugs Ltd.

Kabra Drugs Limited does not have significant operations. Previously, the company was engaged in permaculture manufacturing and trading of pharma related products. Kabra Drugs Limited was incorporated in 1989 and is based in Chennai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
Cipla Ltd.
CIPLA
$11.16B
1.06T INR
181K%
23.4
Lupin Ltd.
LUPIN
$11.04B
1.05T INR
179K%
22.7
Aurobindo Pharma Ltd.
AUROPHARMA
$8.46B
807.02B INR
137K%
23.1
Cohance Lifesciences Ltd.
SUVENPHAR
$1.88B
178.87B INR
30K%
199.0
Granules India Ltd.
GRANULES
$1.83B
174.85B INR
30K%
32.1
Viyash Scientific Ltd.
SEQUENT
$948.78M
90.48B INR
15K%
92.7
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
Teva Pharmaceutical Industries Ltd.
TEVA
$36.75B
108.92B ILS
595K%
24.2
Revolution Medicines, Inc.
RVMD
$29.56B
479K%
-
Zhejiang NHU Company Ltd.
002001
$15.84B
107.34B CNY
256K%
16.0
Haisco Pharmaceutical Group Co., Ltd.
002653
$9.09B
61.6B CNY
147K%
80.6
ABIVAX Société Anonyme
ABVX
$8.74B
7.57B EUR
142K%
-
Dong-E-E-Jiao Co., Ltd.
000423
$5.21B
35.33B CNY
84K%
20.0
chevron_leftBack